We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
LGALS3BP is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
504.8
Number of samples
349
Samples
Sample
Description
TPM
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
1858.1
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
1843.9
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
1729.3
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
1722.1
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
1579.3
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
1564.0
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
1486.7
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
1432.3
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
1407.9
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
1389.4
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
1384.5
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
1371.7
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
1323.3
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
1286.9
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
1206.0
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
1199.8
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
1192.4
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
1153.9
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
1147.3
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
1127.2
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
1120.1
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
1093.3
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
1072.7
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
1034.1
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
1032.7
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
1023.2
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
1018.0
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
977.3
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
963.9
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
962.3
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
953.1
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
939.1
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
935.1
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
934.7
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
932.3
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
929.4
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
913.0
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
896.9
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
890.6
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
888.7
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
877.8
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
866.6
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
861.6
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
843.8
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
843.4
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
834.6
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
818.8
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
816.4
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
816.4
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
814.5
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
811.6
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
804.7
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
793.9
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
756.6
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
753.1
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
751.5
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
751.2
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
751.1
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
748.4
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
742.6
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
734.8
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
729.3
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
722.9
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
718.3
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
712.8
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
707.6
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
705.4
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
704.1
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
701.0
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
692.1
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
691.8
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
688.1
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
687.5
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
682.3
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
680.9
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
674.2
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
663.3
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
661.1
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
659.2
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
658.1
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
657.1
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
655.3
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
653.3
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
653.2
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
646.4
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
645.6
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
642.8
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
639.8
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
633.6
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
628.6
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
627.7
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
621.3
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
618.2
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
610.8
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
610.0
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
604.1
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
600.7
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
597.4
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
596.4
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
593.7
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
588.2
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
587.8
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
587.6
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
585.7
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
585.6
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
585.4
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
583.7
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
578.1
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
576.4
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
576.0
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
573.4
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
572.7
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
564.3
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
561.1
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
552.8
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
548.8
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
545.0
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
544.8
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
543.8
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
543.5
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
539.0
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
538.6
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
538.4
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
537.3
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
537.3
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
530.4
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
528.9
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
527.3
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
514.9
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
513.3
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
512.2
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
510.2
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
509.8
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
507.6
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
504.9
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
501.4
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
501.3
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
497.6
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
496.3
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
493.3
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
492.3
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
488.3
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
487.8
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
487.7
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
482.7
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
480.8
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
479.5
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
478.9
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
477.8
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
477.6
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
477.2
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
477.0
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
476.1
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
474.1
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
469.4
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
466.1
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
466.1
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
464.7
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
463.7
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
460.9
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
459.3
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
458.0
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
457.9
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
456.3
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
453.9
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
449.3
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
448.2
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
447.7
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
446.7
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
442.2
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
441.5
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
441.4
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
437.5
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
432.4
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
429.4
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
423.2
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
421.7
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
419.5
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
418.5
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
416.9
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
407.6
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
406.0
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
404.0
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
402.1
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
401.5
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
400.4
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
400.0
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
399.4
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
399.1
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
396.7
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
395.2
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
393.4
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
392.7
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
392.2
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
390.0
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
388.0
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
387.6
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
383.1
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
380.4
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
379.0
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
378.7
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
376.7
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
376.2
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
375.0
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
373.9
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
373.7
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
372.6
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
370.0
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
369.0
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
368.9
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
368.1
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
365.4
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
364.2
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
363.7
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
359.4
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
357.4
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
354.7
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
353.5
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
352.0
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
349.7
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
349.4
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
347.6
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
346.8
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
343.2
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
340.4
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
338.9
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
338.1
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
337.2
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
336.7
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
336.6
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
335.6
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
333.9
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
331.0
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
325.0
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
324.4
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
323.9
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
322.5
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
319.6
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
318.3
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
318.2
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
313.7
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
313.2
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
312.2
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
310.4
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
309.3
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
307.5
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
304.0
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
303.7
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
301.8
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
301.8
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
299.7
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
299.1
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
298.7
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
298.2
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
296.9
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
296.3
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
295.8
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
293.6
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
287.2
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
285.1
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
285.1
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
283.5
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
281.9
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
280.1
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
279.4
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
278.9
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
278.5
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
277.4
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
276.9
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
275.4
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
273.3
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
269.7
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
268.4
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
267.4
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
262.7
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
262.2
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
261.3
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
257.5
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
254.9
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
253.8
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
249.6
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
248.0
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
246.9
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
244.3
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
244.3
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
243.7
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
243.2
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
242.7
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
242.6
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
240.7
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
239.8
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
233.4
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
233.4
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
228.6
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
227.8
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
225.0
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
224.9
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
224.8
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
224.1
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
223.5
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
222.7
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
221.1
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
220.7
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
219.8
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
219.1
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
217.4
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
217.0
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
214.1
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
213.5
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
210.9
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
202.2
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
197.9
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
190.9
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
189.1
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
188.9
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
188.7
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
186.3
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
183.4
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
177.8
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
176.3
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
175.9
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
175.7
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
171.5
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
170.8
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
167.1
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
163.7
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
162.5
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
155.9
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
148.7
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
144.2
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
138.3
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
138.1
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
136.8
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
132.6
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
129.8
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
127.8
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
123.8
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
120.5
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
109.4
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
99.9
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
96.5
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
95.8
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
91.9
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
91.2
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
78.3
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
77.2
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
76.3
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
70.9
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
LGALS3BP is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
367.3
Number of samples
81
Samples
Sample
Description
TPM
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
1001.7
DO46443
0 years, female, NA, stage:III, dead, 2464 days
875.8
DO46468
0 years, female, NA, stage:III, alive, 2776 days
852.1
DO46329
0 years, female, NA, stage:III, dead, 1699 days
847.7
DO46334
0 years, female, NA, stage:III, dead, 496 days
747.1
DO46364
0 years, female, NA, stage:III, dead, 806 days
674.1
DO46378
0 years, female, NA, stage:III, alive, 843 days
649.4
DO46463
0 years, female, NA, stage:III, dead, 2451 days
623.9
DO46376
0 years, female, NA, stage:III, dead, 1430 days
590.1
DO46348
0 years, female, NA, stage:IV, dead, 287 days
589.6
DO46340
0 years, female, NA, stage:III, dead, 616 days
549.5
DO46586
0 years, female, NA, stage:III, dead, 1019 days
535.4
DO46493
0 years, female, NA, stage:IV, alive, 839 days
524.5
DO46412
0 years, female, NA, stage:III, dead, 597 days
508.3
DO46453
0 years, female, NA, stage:III, dead, 3294 days
506.1
DO46528
0 years, female, NA, stage:III, alive, 6139 days
494.5
DO46568
0 years, female, NA, stage:III, dead, 320 days
492.6
DO46332
0 years, female, NA, stage:III, dead, 689 days
472.2
DO46581
0 years, female, NA, stage:III, dead, 408 days
466.3
DO46408
0 years, female, NA, stage:III, dead, 489 days
459.9
DO46352
0 years, female, NA, stage:III, dead, 677 days
456.9
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
433.8
DO46533
0 years, female, NA, stage:III, alive, 3667 days
430.4
DO46551
0 years, female, NA, stage:III, dead, 1055 days
422.8
DO46350
0 years, female, NA, stage:III, dead, 886 days
421.5
DO46331
0 years, female, NA, stage:III, dead, 612 days
415.7
DO46327
0 years, female, NA, stage:III, dead, 184 days
413.1
DO46358
0 years, female, NA, stage:III, dead, 423 days
411.0
DO46380
0 years, female, NA, stage:III, dead, 1423 days
395.3
DO46591
0 years, female, NA, stage:III, dead, 195 days
393.2
DO46366
0 years, female, NA, stage:III, dead, 2054 days
391.3
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
391.0
DO46576
0 years, female, NA, stage:III, alive, 133 days
390.1
DO46546
0 years, female, NA, stage:III, dead, 1889 days
387.1
DO46436
0 years, female, NA, stage:III, alive, 3193 days
382.7
DO46538
0 years, female, NA, stage:III, dead, 1527 days
377.2
DO46368
0 years, female, NA, stage:III, dead, 2879 days
368.7
DO46342
0 years, female, NA, stage:III, dead, 1398 days
366.5
DO46388
0 years, female, NA, stage:III, dead, 413 days
349.0
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
335.1
DO46354
0 years, female, NA, stage:III, dead, 843 days
317.3
DO46362
0 years, female, NA, stage:III, dead, 1639 days
308.9
DO46336
0 years, female, NA, stage:IV, dead, 664 days
307.2
DO46328
0 years, female, NA, stage:III, dead, 972 days
305.6
DO46602
0 years, female, NA, stage:III, dead, 205 days
304.8
DO46386
0 years, female, NA, stage:III, dead, 1162 days
298.9
DO46448
0 years, female, NA, stage:III, dead, 654 days
296.8
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
293.9
DO46518
0 years, female, NA, stage:III, alive, 2960 days
293.0
DO46404
0 years, female, NA, stage:III, dead, 690 days
290.7
DO46398
0 years, female, NA, stage:III, alive, 437 days
287.0
DO46370
0 years, female, NA, stage:III, dead, 1727 days
284.8
DO46325
0 years, female, NA, stage:III, dead, 477 days
280.4
DO46372
0 years, female, NA, stage:III, dead, 1326 days
277.2
DO46432
0 years, female, NA, stage:III, alive, 2218 days
265.6
DO46344
0 years, female, NA, stage:III, dead, 642 days
259.8
DO46346
0 years, female, NA, stage:III, dead, 1187 days
259.6
DO46390
0 years, female, NA, stage:III, dead, 374 days
256.5
DO46508
0 years, female, NA, stage:III, dead, 2101 days
256.4
DO46330
0 years, female, NA, stage:III, dead, 684 days
255.9
DO46382
0 years, female, NA, stage:IV, dead, 311 days
250.4
DO46597
0 years, female, NA, stage:III, dead, 393 days
239.4
DO46560
0 years, female, NA, stage:IV, dead, 286 days
229.6
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
222.2
DO46326
0 years, female, NA, stage:III, dead, 701 days
220.7
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
209.9
DO46571
0 years, female, NA, stage:III, dead, 243 days
203.7
DO46400
0 years, female, NA, stage:III, dead, 719 days
197.5
DO46392
0 years, female, NA, stage:III, dead, 628 days
181.5
DO46374
0 years, female, NA, stage:III, dead, 1409 days
180.6
DO46396
0 years, female, NA, stage:III, dead, 583 days
178.1
DO46561
0 years, female, NA, stage:III, dead, 195 days
177.3
DO46338
0 years, female, NA, stage:III, dead, 596 days
165.0
DO46356
0 years, female, NA, stage:III, dead, 911 days
158.6
DO46384
0 years, female, NA, stage:III, dead, 614 days
153.7
DO46402
0 years, female, NA, stage:III, dead, 511 days
147.9
DO46566
0 years, female, NA, stage:III, dead, 673 days
137.2
DO46333
0 years, female, NA, stage:III, dead, 359 days
134.8
DO46611
0 years, female, NA, stage:III, dead, 734 days
134.0
DO46588
0 years, female, NA, stage:III, dead, 438 days
111.9
DO46606
0 years, female, NA, stage:III, alive, 804 days
29.6
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
2f901c90-617e-46da-9fac-d68369_D2
Tumor
1.8
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
1.7
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
1.7
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
1.4
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
1.3
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
1.2
10c2d629-0287-4511-ac25-f29031_D2
Tumor
1.2
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
1.2
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
1.2
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
1.1
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
1.1
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
1.1
285fed94-1495-448e-879b-b55de9_D2
Tumor
1.1
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
1.0
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.9
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
0.9
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.9
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.9
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.9
15524912-685a-47ce-a824-567848_D2
Tumor
0.8
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
0.8
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
0.8
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
0.8
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
0.8
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.7
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.7
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
0.7
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.7
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
0.7
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
0.7
e9d416e7-f661-400a-896e-388545_D2
Tumor
0.6
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
0.6
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.6
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
0.5
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.5
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
0.4
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
0.4
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
0.4
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
0.4
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
0.4
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.4
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
0.4
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.4
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.4
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
0.4
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.4
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
0.4
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
0.3
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
0.3
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.3
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.3
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.3
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
0.3
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.3
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.3
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.3
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.2
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.2
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.2
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.2
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
0.2
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.2
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
0.2
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
0.2
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
0.2
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.2
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.1
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.1
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.1
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.1
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
0.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.1
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
0.0
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.0
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
0.0
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
0.0
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.0
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
0.0
a3a26070-fb84-406a-8280-d555e6_D2
Normal
0.0
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-0.1
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.1
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
-0.1
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.1
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-0.1
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.1
161317f3-1a39-438e-af45-cd2502_D2
Tumor
-0.1
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.1
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
-0.1
340a3769-3031-41ae-bb08-a2f696_D2
Normal
-0.2
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.2
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-0.2
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
-0.2
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-0.2
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-0.2
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.3
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-0.3
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-0.3
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
-0.3
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-0.3
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.3
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-0.3
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.3
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-0.3
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.4
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.4
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-0.4
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-0.5
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.5
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.